Amedisys [AMED] vs Tenet Healthcare [THC] Detailed Stock Comparison
Amedisys
NASDAQ
Loading...
Tenet Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Amedisys wins in 4 metrics, Tenet Healthcare wins in 15 metrics, with 0 ties. Tenet Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Amedisys | Tenet Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 38.63 | 10.41 | Tenet Healthcare |
| Price-to-Book Ratio | 2.65 | 3.90 | Amedisys |
| Debt-to-Equity Ratio | 35.34 | 158.70 | Amedisys |
| PEG Ratio | 19.43 | 14.45 | Tenet Healthcare |
| EV/EBITDA | 13.52 | 6.86 | Tenet Healthcare |
| Profit Margin (TTM) | 3.56% | 7.18% | Tenet Healthcare |
| Operating Margin (TTM) | 11.70% | 16.13% | Tenet Healthcare |
| EBITDA Margin (TTM) | 11.70% | 16.13% | Tenet Healthcare |
| Return on Equity | 6.67% | 29.65% | Tenet Healthcare |
| Return on Assets (TTM) | 6.52% | 7.58% | Tenet Healthcare |
| Free Cash Flow (TTM) | $214.29M | $1.12B | Tenet Healthcare |
| 1-Year Return | 3.24% | 10.34% | Tenet Healthcare |
| Price-to-Sales Ratio (TTM) | 1.36 | 0.71 | Tenet Healthcare |
| Enterprise Value | $3.42B | $29.73B | Tenet Healthcare |
| EV/Revenue Ratio | 1.42 | 1.44 | Amedisys |
| Gross Profit Margin (TTM) | 43.96% | 82.32% | Tenet Healthcare |
| Revenue per Share (TTM) | $73 | $220 | Tenet Healthcare |
| Earnings per Share (Diluted) | $2.57 | $15.91 | Tenet Healthcare |
| Beta (Stock Volatility) | 0.90 | 1.52 | Amedisys |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Amedisys vs Tenet Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Amedisys | 0.06% | 2.47% | 3.35% | 6.03% | 9.68% | 11.05% |
| Tenet Healthcare | 1.32% | 4.74% | -3.95% | 11.08% | 18.74% | 32.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Amedisys | 3.24% | -17.52% | -56.18% | 122.39% | 322.79% | 231.32% |
| Tenet Healthcare | 10.34% | 147.21% | 469.39% | 217.32% | 892.69% | 224.92% |
Performance & Financial Health Analysis: Amedisys vs Tenet Healthcare
| Metric | AMED | THC |
|---|---|---|
| Market Information | ||
| Market Cap | $3.27B | $14.63B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 719,530 | 1,184,080 |
| 90 Day Avg. Volume | 516,367 | 1,521,937 |
| Last Close | $100.94 | $165.58 |
| 52 Week Range | $82.15 - $100.99 | $109.82 - $185.25 |
| % from 52W High | -0.05% | -10.62% |
| All-Time High | $325.12 (Jan 25, 2021) | $210.00 (Sep 30, 2002) |
| % from All-Time High | -68.95% | -21.15% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.03% |
| Quarterly Earnings Growth | -0.13% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.07% |
| Operating Margin (TTM) | 0.12% | 0.16% |
| Return on Equity (TTM) | 0.07% | 0.30% |
| Debt to Equity (MRQ) | 35.34 | 158.70 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $37.48 | $42.44 |
| Cash per Share (MRQ) | $10.26 | $29.71 |
| Operating Cash Flow (TTM) | $239.42M | $2.46B |
| Levered Free Cash Flow (TTM) | $300.69M | $886.75M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Amedisys vs Tenet Healthcare
| Metric | AMED | THC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 38.63 | 10.41 |
| Forward P/E | 19.43 | 14.45 |
| PEG Ratio | 19.43 | 14.45 |
| Price to Sales (TTM) | 1.36 | 0.71 |
| Price to Book (MRQ) | 2.65 | 3.90 |
| Market Capitalization | ||
| Market Capitalization | $3.27B | $14.63B |
| Enterprise Value | $3.42B | $29.73B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.42 | 1.44 |
| Enterprise to EBITDA | 13.52 | 6.86 |
| Risk & Other Metrics | ||
| Beta | 0.90 | 1.52 |
| Book Value per Share (MRQ) | $37.48 | $42.44 |
Financial Statements Comparison: Amedisys vs Tenet Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMED | THC |
|---|---|---|
| Revenue/Sales | $621.86M | $5.22B |
| Cost of Goods Sold | $348.47M | $907.00M |
| Gross Profit | $273.39M | $4.32B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $72.74M | $901.00M |
| EBITDA | $97.35M | $1.19B |
| Pre-Tax Income | $48.33M | $765.00M |
| Income Tax | $19.27M | $143.00M |
| Net Income (Profit) | $29.05M | $622.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMED | THC |
|---|---|---|
| Cash & Equivalents | $337.30M | $3.00B |
| Total Current Assets | $662.20M | $7.91B |
| Total Current Liabilities | $488.36M | $4.45B |
| Long-Term Debt | $386.83M | $13.08B |
| Total Shareholders Equity | $1.27B | $8.65B |
| Retained Earnings | $880.25M | $3.41B |
| Property, Plant & Equipment | $229.50M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMED | THC |
|---|---|---|
| Operating Cash Flow | $75.50M | $832.00M |
| Capital Expenditures | $-696,000 | $-162.00M |
| Free Cash Flow | $66.29M | $642.00M |
| Debt Repayment | N/A | $-32.00M |
| Common Stock Repurchase | N/A | $-348.00M |
Short Interest & Institutional Ownership Analysis
| Metric | AMED | THC |
|---|---|---|
| Shares Short | 2.24M | 2.92M |
| Short Ratio | 4.66 | 1.90 |
| Short % of Float | 0.07% | 0.04% |
| Average Daily Volume (10 Day) | 719,530 | 1,184,080 |
| Average Daily Volume (90 Day) | 516,367 | 1,521,937 |
| Shares Outstanding | 32.78M | 95.11M |
| Float Shares | 32.24M | 87.62M |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 0.93% | 1.05% |
Dividend Analysis & Yield Comparison: Amedisys vs Tenet Healthcare
| Metric | AMED | THC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |